508 related articles for article (PubMed ID: 28110692)
1. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
Wu X; Tüzün E
Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
[TBL] [Abstract][Full Text] [Related]
2. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
[TBL] [Abstract][Full Text] [Related]
3. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
4. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis.
Vincent A; Willcox N; Hill M; Curnow J; MacLennan C; Beeson D
Immunol Rev; 1998 Aug; 164():157-68. PubMed ID: 9795773
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
[TBL] [Abstract][Full Text] [Related]
6. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
7. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.
Tüzün E; Allman W; Ulusoy C; Yang H; Christadoss P
Ann N Y Acad Sci; 2012 Dec; 1274():133-9. PubMed ID: 23252908
[TBL] [Abstract][Full Text] [Related]
8. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunizing mechanisms in thymoma and thymus.
Willcox N; Leite MI; Kadota Y; Jones M; Meager A; Subrahmanyam P; Dasgupta B; Morgan BP; Vincent A
Ann N Y Acad Sci; 2008; 1132():163-73. PubMed ID: 18567866
[TBL] [Abstract][Full Text] [Related]
10. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.
Ostlie NS; Karachunski PI; Wang W; Monfardini C; Kronenberg M; Conti-Fine BM
J Immunol; 2001 Apr; 166(8):4853-62. PubMed ID: 11290761
[TBL] [Abstract][Full Text] [Related]
11. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
[TBL] [Abstract][Full Text] [Related]
12. A new mouse model of autoimmune ocular myasthenia gravis.
Yang H; Wu B; Tüzün E; Saini SS; Li J; Allman W; Higgs S; Xiao TL; Christadoss P
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5101-11. PubMed ID: 17962462
[TBL] [Abstract][Full Text] [Related]
13. Differences between ocular and generalized myasthenia gravis: binding characteristics of anti-acetylcholine receptor antibody against bovine muscles.
Hayashi M; Kida K; Yamada I; Matsuda H; Tsuneishi M; Tamura O
J Neuroimmunol; 1989 Feb; 21(2-3):227-33. PubMed ID: 2913046
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
[TBL] [Abstract][Full Text] [Related]
15. The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis.
Dedhia V; Goluszko E; Wu B; Deng C; Christadoss P
Clin Immunol Immunopathol; 1998 Jun; 87(3):266-75. PubMed ID: 9646836
[TBL] [Abstract][Full Text] [Related]
16. Scenarios for autoimmunization of T and B cells in myasthenia gravis.
Shiono H; Roxanis I; Zhang W; Sims GP; Meager A; Jacobson LW; Liu JL; Matthews I; Wong YL; Bonifati M; Micklem K; Stott DI; Todd JA; Beeson D; Vincent A; Willcox N
Ann N Y Acad Sci; 2003 Sep; 998():237-56. PubMed ID: 14592881
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.
Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J
Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452
[TBL] [Abstract][Full Text] [Related]
18. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
Oda K; Shibasaki H
Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis with anti-acetylcholine receptor antibodies.
Meriggioli MN
Front Neurol Neurosci; 2009; 26():94-108. PubMed ID: 19349707
[TBL] [Abstract][Full Text] [Related]
20. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]